Belatacept 3 Month Post Transplant Conversion Study

NCT02213068 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

28

Enrollment

OTHER

Sponsor class

Conditions

Transplant; Failure, Kidney
EBV

Interventions

DRUG: belatacept
DRUG: Tacrolimus
DRUG: MPA

Sponsor

Lorenzo Gallon

Collaborators

[object Object]